WASHINGTON (Reuters) – U.S. drug reviewers on Tuesday said Roche Holding AG’s eye drug Lucentis
(ranibizumab injection) appeared to help patients with diabetic macular edema (DME), but questioned whether two
different doses of the drug were equ…
Month: July 2012
Prolonged Dietary Selenium Deficiency or Excess Does Not Globally Affect Selenoprotein Gene Expression and/or Protein Production in Various Tissues of Pigs
By: leilab
Gene Therapy in Ophthalmology Update 13: New Clinical Site for Usher Syndrome Clinical Trials
In joint news releases, both the Foudation Fighting Blindness (FFB) and Oxford BioMedica announced that FFB had recently awarded $125,000 to the Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, a clinical trial site for UshStat, a gene th…
Tiny microneedles to treat macular degeneration
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses – and …
CHMP recommends adoption of two new contra-indications for dexamethasone intravitreal implant (Ozurdex®)
Source: No information given
Area: News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the adoption of two new contraindications for Ozurdex® (dexamethasone…
Foundation Fighting Blindness grants US$125,000 to Oxford BioMedica for UshStat Phase I/IIa trial
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, …
What’s in Name? Lots, Says JAMA
(MedPage Today) — An ongoing redesign of the JAMA specialty journals will include a new name for each of the publications, according to a statement from JAMA Network.
Agreement Among Glaucoma Tests Higher Than Thought
Researchers find that agreement among screening tests may be better than summary statistics suggest in patients with glaucoma. Medscape Medical News
RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases
Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Ch…
Energy intake and expenditure during sedentary screen time and motion-controlled video gaming
By: LIZ_LYONS
Gene Therapy in Ophthalmology Update 12: First Gene Therapy Approval on the Horizon
As Andrew Pollack writes in today’s NYTimes, “After more than two decades of dashed expectations, the field of gene therapy appears close to reaching a milestone: a regulatory approval. The European Medicines Agency has recommended approval of a ge…
Diagnosis, Treatment, and Follow-up of Patients With AMD
How well does the VEGF inhibitor, ranibizumab, work in patients with age-related macular degeneration, and are there new methods available for diagnosing the disease? This new study explains. Expert Review of Ophthalmology
The Pharmacological Treatment of Acquired Nystagmus
This review summarizes current treatment approaches to acquired nystagamus, a condition characterized by involuntary eye movements. Practical Neurology
Prepregnancy adherence to dietary patterns and lower risk of gestational diabetes mellitus
By: dtobias
Femtolaser Cataract Surgery: Conquering the Learning Curve
Ophthalmic surgeons report their experiences — both good and bad — with femtosecond laser cataract surgery. Medscape Ophthalmology
Neuroprotective Strategies in Glaucoma
With no cure on the horizon, neuroprotective strategies may be the best option for this neurodegenerative disease. Medscape Ophthalmology
Pivotal AMD Treatment Studies Update
Results of treatment trials for exudative AMD and choroidal neovascularization are summarized. Medscape Ophthalmology
Risk factors defined for retinal detachment after cataract surgery
Study results spanning 22 years show that the risk for retinal detachment after undergoing phacoemulsification for cataracts has fallen dramatically, but that younger, and male patients are more at risk for this adverse outcome than their older, female…
CNTF Implants for CNGB3 Achromatopsia
Status: Recruiting,
Condition Summary: Eye Disease; Achromatopsia
Consumers Overconfident About Eye Health
Consumers confidently hold many mistaken beliefs about eye health. This results in risky behaviors and neglect that could endanger vision and overall health. Medscape Medical News